[{"bbox": [90, 98, 370, 133], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [90, 200, 1258, 234], "category": "Text", "text": "Except as stated below, there have been no changes in our Company's auditors in the last three (3) years:"}, {"bbox": [90, 260, 1558, 975], "category": "Table", "text": "<table><thead><tr><td>Details of Statutory Auditor</td><td>Date of Change</td><td>Reason of Change</td></tr></thead><tbody><tr><td>Mayank Mehrotra & Associates<br>Address: 316, Murli Bhawan, 10-A, Ashok Road, Lucknow, Uttar Pradesh, 226001<br>Tel: 9935599100<br>Email: camayankmehrotra@gmail.com<br>Contact Person: CA Mayank Mehrotra<br>FRN: 022941C</td><td>Appointed as Statutory Auditor on September 30, 2022</td><td>Re-appointment as Statutory Auditor of the Company.</td></tr><tr><td>Mayank Mehrotra & Associates<br>Address: 316, Murli Bhawan, 10-A, Ashok Road, Lucknow, Uttar Pradesh, 226001<br>Tel: 9935599100<br>Email: camayankmehrotra@gmail.com<br>Contact Person: CA Mayank Mehrotra<br>FRN: 022941C</td><td>Resigned as Statutory Auditor on January 18, 2025</td><td>Resigned as Statutory Auditor due to preoccupation with other professional commitments</td></tr><tr><td>R K JAGETIYA & CO.<br>Address: B-303, Eklavya CHSL, N L Complex, Dahisar East, Mumbai, Maharashtra, 400068<br>Tel: 9820800926<br>Email: rkjagetiyoaco@gmail.com<br>Contact Person: CA Ravi K Jagetiya<br>FRN: 146264W</td><td>Appointed as Statutory Auditor on January 25, 2025</td><td>Appointment as Statutory Auditor to fill casual vacancy</td></tr></tbody></table>"}, {"bbox": [90, 1007, 363, 1041], "category": "Section-header", "text": "## Book Building Process"}, {"bbox": [90, 1070, 1561, 1296], "category": "Text", "text": "Book Building, with reference to the Issue, refers to the process of collection of Bids on the basis of the Red Herring Prospectus within the Price Band. The Price Band shall be determined by our Company in consultation with the Book Running Lead Managers in accordance with the Book Building Process, and advertised in all editions of the English national newspaper [●] and all editions of Hindi national newspaper [●] and edition of regional newspaper [●] where our registered office is situated at least two working days prior to the Bid / Issue Opening date. The Issue Price shall be determined by our Company, in consultation with the Book Running Lead Managers in accordance with the Book Building Process after the Bid / Issue Closing Date. Principal parties involved in the Book Building Process are: -"}, {"bbox": [90, 1329, 312, 1362], "category": "List-item", "text": "* Our Company;"}, {"bbox": [90, 1364, 1558, 1396], "category": "List-item", "text": "* The Book Running Lead Managers in this case being Hem Securities Limited and Share India Capital Services Private Limited,"}, {"bbox": [90, 1396, 1558, 1462], "category": "List-item", "text": "* The Syndicate Member(s) who are intermediaries registered with SEBI / registered as brokers with BSE or NSE and eligible to act as Underwriters. The Syndicate Member(s) will be appointed by the Book Running Lead Managers;"}, {"bbox": [90, 1462, 485, 1495], "category": "List-item", "text": "* The Registrar to the Issue and;"}, {"bbox": [90, 1497, 693, 1530], "category": "List-item", "text": "* The Designated Intermediaries and Sponsor bank"}, {"bbox": [90, 1559, 1558, 1626], "category": "Text", "text": "The SEBI (ICDR) Regulations have permitted the Issue of securities to the public through the Book Building Process, wherein allocation to the public shall be made as per Regulation 253 of the SEBI (ICDR) Regulations."}, {"bbox": [90, 1655, 1561, 2137], "category": "Text", "text": "The Issue is being made through the Book Building Process wherein not more than 50% of the Net Issue shall be available for allocation on a proportionate basis to QIBs, provided that our Company may in consultation with the Book Running Lead Managers allocate upto 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI (ICDR) Regulations (the \"Anchor Investor Portion\"), out of which one third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Issue Price. 5% of the QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. Further, not less than 15% of the Net Issue shall be available for allocation on a proportionate basis to Non-Institutional Bidders in the following manner: (a) 1/3rd of the portion available to NIBs shall be reserved for applicants with an application size of more than 2 lots and up to such lots equivalent to not more than ₹ 10 lakhs (b) 2/3rd of the portion available to NIBs shall be reserved for applicants with an application size of more than ₹ 10 lakhs and the unsubscribed portion in either of the sub-categories specified in clauses (a) or (b), could be allocated to applicants in the other sub-category of NIBs and the remaining shares, if any, shall be allotted on a proportionate basis in accordance with the conditions specified in this regards in Schedule XIII of SEBI ICDR Regulations and not less than 35% of the Net Issue shall be available for allocation to Individual Bidders, who applies for minimum application size, in accordance with the SEBI Regulations, subject to valid Bids being received at or above the Issue Price."}]